Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Histamine-1 Receptor Antagonist [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CETIRIZINE 47,655 4,787 10.0% 8,423 4,910 46.4 yrs 83.6%
DIPHENHYDRAMINE 25,827 10,508 40.7% 6,849 1,658 44.7 yrs 72.2%
FEXOFENADINE 21,453 80 0.4% 535 111 55.9 yrs 68.4%
LEVOCETIRIZINE 10,782 554 5.1% 884 256 49.1 yrs 72.0%
OLOPATADINE 8,787 89 1.0% 171 23 56.7 yrs 73.2%
AZELASTINE 5,896 12 0.2% 89 16 62.6 yrs 67.1%
DESLORATADINE 3,141 160 5.1% 1,389 272 47.8 yrs 61.7%
DIMENHYDRINATE 1,934 160 8.3% 836 287 45.4 yrs 73.8%
CHLORPHENIRAMINE 1,919 607 31.6% 663 240 44.1 yrs 48.1%
ALCAFTADINE 465 0 N/A 4 1 56.0 yrs 80.3%

Head-to-Head Comparisons

CETIRIZINE vs DIPHENHYDRAMINE CETIRIZINE vs FEXOFENADINE CETIRIZINE vs LEVOCETIRIZINE CETIRIZINE vs OLOPATADINE DIPHENHYDRAMINE vs FEXOFENADINE DIPHENHYDRAMINE vs LEVOCETIRIZINE DIPHENHYDRAMINE vs OLOPATADINE FEXOFENADINE vs LEVOCETIRIZINE FEXOFENADINE vs OLOPATADINE LEVOCETIRIZINE vs OLOPATADINE
← Back to Histamine-1 Receptor Antagonist [EPC] Class side effects →